PENMENVY
LIVE

Serial Number

97251141

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Feb 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PENMENVY Trademark

Serial Number: 97251141 • Registration: 7160470

PENMENVY is a trademark filed by GlaxoSmithKline Biologicals SA on February 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

February 2, 2022

Registration Date

September 12, 2023

Published for Opposition

June 27, 2023

Goods & Services

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 12, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 12, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 27, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 7, 2023 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 24, 2023 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2023 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 26, 2023 CHAN
ASSIGNED TO LIE
Apr 25, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 25, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 16, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 16, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 16, 2022 CNSL
ASSIGNED TO EXAMINER
Nov 15, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2022 NWOS
NEW APPLICATION ENTERED
Feb 5, 2022 NWAP